Where I see patients (3)
My reviews
Selected research
-
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
-
Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant.
Scientific reports
-
Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors.
Breast cancer research : BCR
Clinical trials
A Study of MGC028 in Participants With Advanced Solid Tumors
Types of AEs include Serious Adverse Events (SAEs), and AEs Leading to Treatment Delay or Discontinuation or Dose Reduction, dose limiting toxicities, and AEs of Special Interest. Observation of side effects determines the highest...
Recruiting
4.8